5 min
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech The Biopharma Pod
-
- Business News
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
5 min